Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/26 18:30 | 4/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Hannay Michael Charles Ferguson | O | CHIEF PR | 5 | S.dm | -60 | 6.59 | 0 | -9 | 98 | D | ||||||||||||||||
4/6/26 18:30 | 4/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Thompson Travis Alvin | O | CFO | 5 | S.dm | -28 | 6.54 | 0 | -4 | 66 | D | ||||||||||||||||
4/6/26 18:30 | 4/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Perry Jennifer Scott | O | COO | 1 | S.m | -7 | 4.94 | 0 | -1 | 92 | D | ||||||||||||||||
4/6/26 18:30 | 4/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Lee Kevin | DO | CEO | 5 | S.dm | -309 | 6.77 | 0 | -46 | 619 | D | ||||||||||||||||
4/6/26 18:30 | 4/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Skynner Michael | O | CHIEF SC | 5 | S.dm | -96 | 6.79 | 0 | -14 | 162 | D | ||||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Milnes Alistair | X0 | O | COO | 4 | S.dm | -94 | 7.20 | 0 | -13 | 137 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Young Alethia | X0 | O | CFO | 4 | S.dm | -58 | 6.78 | 0 | -9 | 87 | D | |||||||||||||||
10/6/25 16:45 | 10/2/25 | BCYC | Health | Drug | Pharmaceutical Preparations | Swanton Robert Charles | X0 | D | 1 | S | -1 | 8.55 | 0 | 0 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |